The ability of LB-100 to modify P-gp levels was examined at the transcriptional and protein levels in glioblastoma and NSCLC MDR models, which exhibit overexpression of P-gp, compared to their sensitive counterpart cells. The gene discussed is PGP; the disease is non-small cell lung carcinoma.